Thomas Prebet
18PUBLICATIONS
29CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (18)
Sort by Publication Date:
|Sep 06, 2024
Healthcare Utilization and Costs Among Patients with Acute Myeloid Leukemia Receiving Oral Azacitidine Maintenance Therapy Versus No Maintenance: A US Claims Database Study.Uma Borate, Karen Seiter, Ravi Potluri
|Nov 12, 2023
Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML-001.Farhad Ravandi, Hartmut Döhner, Andrew H Wei
|May 02, 2022
A phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemia.Thomas Prebet, Aaron D Goldberg, Joseph G Jurcic
|Mar 11, 2022
In vivo anti-tumor effect of PARP inhibition in IDH1/2 mutant MDS/AML resistant to targeted inhibitors of mutant IDH1/2.Rana Gbyli, Yuanbin Song, Wei Liu
|Sep 03, 2021
Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant.Jan Philipp Bewersdorf, Andriy Derkach, Lohith Gowda
|May 28, 2021
Current challenges and unmet medical needs in myelodysplastic syndromes.Uwe Platzbecker, Anne Sophie Kubasch, Collin Homer-Bouthiette
Pageof 3
Frequent Collaborators
3 joint publications
Jan Philipp Bewersdorf
1 joint publications
Aref Al-Kali
1 joint publications
Mark Litzow
1 joint publications
Namrata S Chandhok
1 joint publications
Rory Shallis
1 joint publications
Brian A Jonas
1 joint publications
Uwe Platzbecker
1 joint publications
Anne Sophie Kubasch
1 joint publications
Boglarka Gyurkocza
1 joint publications
Rana Gbyli
